Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP14 | P54578 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.34 |
| ▸ | ITK | Q08881 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21108748 | 0.94 | PTGER4 (0.36) | USP14CYP19A1ALDH1A1CYP2A6GRM2 | |
| SCHEMBL21108006 | 0.91 | USP14 (0.35) | USP14ALDH1A1CYP2A6GRM5 | |
| SCHEMBL22563430 | 0.90 | USP14 (0.38) | USP14CYP19A1ALDH1A1CYP2A6GRM2 | |
| SCHEMBL19943041 | 0.89 | CHEK1 (0.39) | ALDH1A1CYP2A6GRM2 | |
| SCHEMBL19942583 | 0.88 | CHEK1 (0.35) | ALDH1A1GRM2 | |
| SCHEMBL21108351 | 0.87 | CHEK1 (0.41) | GRM2 | |
| SCHEMBL19943112 | 0.87 | CHEK1 (0.35) | GRM2GRM5 | |
| SCHEMBL19943043 | 0.86 | CHEK1 (0.36) | — | |
| SCHEMBL19943115 | 0.86 | CHEK1 (0.34) | GRM2 | |
| SCHEMBL21108749 | 0.85 | KIF11 (0.36) | CYP19A1GRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492344-B2 | Organic molecules for use in organic optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-11-08 | — | — | US | disclosed |
| EP-3507285-B1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2020-10-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492344-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OCIAD2, OR51E2 | USP14 4066/4885CYP19A1 2258/4885ALDH1A1 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.